Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-12-09 Sale | 2022-12-13 5:16 pm | Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP, Global Head of R&D | 1,844 | $151.54 | $279,440 | 36,316 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-05 Tax Withholding | 2024-03-07 9:47 pm | N/A N/A | Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP, Global Head of R&D | 4,294 | $117.53 | 62,226 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 7:47 pm | N/A N/A | Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP, Global Head of R&D | 16,928 | $0 | 66,520 (Direct) | View |
| 2024-01-17 Tax Withholding | 2024-01-19 6:25 pm | N/A N/A | Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP, Global Head of R&D | 1,730 | $119.13 | 49,592 (Direct) | View |
| 2024-01-17 Option Award | 2024-01-19 6:25 pm | N/A N/A | Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP, Global Head of R&D | 5,970 | $0 | 49,592 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 7:55 pm | 2024-06-13 2033-06-13 | iTeos Therapeutics Inc. | ITOS | Iannone Robert Director | 22,383 | $0 | 22,383 (Direct) | View |
| 2023-06-05 Disposition | 2023-06-07 7:16 pm | N/A N/A | Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP, Global Head of Research a | 1,311 | $129.73 | 45,315 (Direct) | View |
| 2023-05-03 Disposition | 2023-05-04 07:43 am | N/A N/A | Jounce Therapeutics Inc. | JNCE | Iannone Robert Director | 74,950 | $0 | 0 (Direct) | View |
| 2023-03-03 Option Award | 2023-03-07 9:22 pm | N/A N/A | Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP, Global Head of Research a | 12,447 | $0 | 46,489 (Direct) | View |
| 2023-03-05 Tax Withholding | 2023-03-07 9:22 pm | N/A N/A | Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP, Global Head of Research a | 2,274 | $142.78 | 46,489 (Direct) | View |
| 2022-06-24 Option Award | 2022-06-28 9:05 pm | N/A 2032-06-24 | Jounce Therapeutics Inc. | JNCE | Iannone Robert Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 7:53 pm | N/A 2032-06-09 | iTeos Therapeutics Inc. | ITOS | Iannone Robert Director | 17,538 | $0 | 17,538 (Direct) | View |
| 2022-06-06 Tax Withholding | 2022-06-08 5:01 pm | N/A N/A | Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP, Global Head of R&D | 1,295 | $149.25 | 38,109 (Direct) | View |
| 2022-03-03 Option Award | 2022-03-09 5:54 pm | N/A N/A | Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP, Global Head of R&D and Ch | 11,374 | $0 | 39,257 (Direct) | View |
| 2022-03-05 Tax Withholding | 2022-03-09 5:54 pm | N/A N/A | Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP, Global Head of R&D and Ch | 1,327 | $153.96 | 39,257 (Direct) | View |
| 2021-06-18 Option Award | 2021-06-22 4:47 pm | N/A 2031-06-18 | Jounce Therapeutics Inc. | JNCE | Iannone Robert Director | 15,700 | $0 | 15,700 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-21 8:24 pm | N/A 2031-06-17 | iTeos Therapeutics Inc. | ITOS | Iannone Robert Director | 4,560 | $0 | 4,560 (Direct) | View |
| 2021-06-05 Tax Withholding | 2021-06-09 6:57 pm | N/A N/A | Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP R&D, Chief Medical Officer | 1,206 | $176.47 | 29,086 (Direct) | View |
| 2021-04-29 Option Award | 2021-05-03 7:09 pm | N/A 2031-04-29 | iTeos Therapeutics Inc. | ITOS | Iannone Robert Director | 33,217 | $0 | 0 (Direct) | View |
| 2021-03-05 Tax Withholding | 2021-03-09 7:30 pm | N/A N/A | Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP R&D, Chief Medical Officer | 741 | $164.75 | 30,145 (Direct) | View |
| 2021-02-25 Option Award | 2021-03-01 5:55 pm | N/A N/A | Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP, Research & Development | 8,535 | $0 | 30,886 (Direct) | View |
| 2020-06-26 Option Award(A) | 2020-07-02 7:35 pm | N/A 2030-06-26 | Jounce Therapeutics Inc. | JNCE | Iannone Robert Director | 7,850 | $0 | 7,850 (Direct) | View |
| 2020-06-26 Option Award | 2020-06-29 7:32 pm | N/A 2030-06-26 | Jounce Therapeutics Inc. | JNCE | Iannone Robert Director | 6,775 | $0 | 6,775 (Direct) | View |
| 2020-06-05 Tax Withholding | 2020-06-05 9:38 pm | N/A N/A | Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP, Research & Development | 943 | $120.65 | 22,204 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-02 6:32 pm | N/A 2030-02-26 | Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP, Research & Development | 37,800 | $0 | 50,000 (Direct) | View |
| 2020-01-21 Option Award | 2020-01-23 08:08 am | N/A 2030-01-21 | Jounce Therapeutics Inc. | JNCE | Iannone Robert Director | 31,400 | $0 | 31,400 (Direct) | View |
| 2019-08-08 Option Award | 2019-08-12 4:59 pm | N/A 2029-08-07 | Jazz Pharmaceuticals plc | JAZZ | Iannone Robert EVP, Research & Development | 42,700 | $0 | 42,700 (Direct) | View |